Literature DB >> 15794920

The role of HNF4A variants in the risk of type 2 diabetes.

Karen L Mohlke1, Michael Boehnke.   

Abstract

Genes influence susceptibility to type 2 diabetes mellitus (T2DM), and both positional cloning and candidate gene approaches have been used to identify these genes. Linkage analysis has generated evidence for T2DM-predisposing variants on chromosome 20q in studies of Caucasians, Asians, and Africans, and fine-mapping recently identified a likely susceptibility gene, hepatocyte nuclear factor 4-alpha (HNF4A). Rare loss-of-function mutations in HNF4A cause maturity-onset diabetes of the young and now common noncoding variants have been found to be associated with T2DM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15794920     DOI: 10.1007/s11892-005-0043-y

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  68 in total

1.  High-throughput screening for evidence of association by using mass spectrometry genotyping on DNA pools.

Authors:  Karen L Mohlke; Michael R Erdos; Laura J Scott; Tasha E Fingerlin; Anne U Jackson; Kaisa Silander; Pablo Hollstein; Michael Boehnke; Francis S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

2.  Increasing the power and efficiency of disease-marker case-control association studies through use of allele-sharing information.

Authors:  Tasha E Fingerlin; Michael Boehnke; Gonçalo R Abecasis
Journal:  Am J Hum Genet       Date:  2004-02-02       Impact factor: 11.025

3.  E23K single nucleotide polymorphism in the islet ATP-sensitive potassium channel gene (Kir6.2) contributes as much to the risk of Type II diabetes in Caucasians as the PPARgamma Pro12Ala variant.

Authors:  L Love-Gregory; J Wasson; J Lin; G Skolnick; B Suarez; M A Permutt
Journal:  Diabetologia       Date:  2003-01       Impact factor: 10.122

4.  A transcription factor regulatory circuit in differentiated pancreatic cells.

Authors:  S F Boj; M Parrizas; M A Maestro; J Ferrer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

5.  A missense mutation in hepatocyte nuclear factor-4 alpha, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus.

Authors:  E H Hani; L Suaud; P Boutin; J C Chèvre; E Durand; A Philippi; F Demenais; N Vionnet; H Furuta; G Velho; G I Bell; B Laine; P Froguel
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

6.  Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus.

Authors:  Y Horikawa; N Oda; N J Cox; X Li; M Orho-Melander; M Hara; Y Hinokio; T H Lindner; H Mashima; P E Schwarz; L del Bosque-Plata; Y Horikawa; Y Oda; I Yoshiuchi; S Colilla; K S Polonsky; S Wei; P Concannon; N Iwasaki; J Schulze; L J Baier; C Bogardus; L Groop; E Boerwinkle; C L Hanis; G I Bell
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

7.  No evidence for linkage at candidate type 2 diabetes susceptibility loci on chromosomes 12 and 20 in United Kingdom Caucasians.

Authors:  T M Frayling; M I McCarthy; M Walker; J C Levy; S O'Rahilly; G A Hitman; P V Rao; A J Bennett; E C Jones; S Menzel; S Ellard; A T Hattersley
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

Review 8.  The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits.

Authors:  Jose C Florez; Joel Hirschhorn; David Altshuler
Journal:  Annu Rev Genomics Hum Genet       Date:  2003       Impact factor: 8.929

Review 9.  A comprehensive review of genetic association studies.

Authors:  Joel N Hirschhorn; Kirk Lohmueller; Edward Byrne; Kurt Hirschhorn
Journal:  Genet Med       Date:  2002 Mar-Apr       Impact factor: 8.822

10.  The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes.

Authors:  S Ghosh; R M Watanabe; T T Valle; E R Hauser; V L Magnuson; C D Langefeld; D S Ally; K L Mohlke; K Silander; K Kohtamäki; P Chines; J Balow; G Birznieks; J Chang; W Eldridge; M R Erdos; Z E Karanjawala; J I Knapp; K Kudelko; C Martin; A Morales-Mena; A Musick; T Musick; C Pfahl; R Porter; J B Rayman
Journal:  Am J Hum Genet       Date:  2000-10-13       Impact factor: 11.043

View more
  14 in total

Review 1.  Nuclear hormone receptors in diabetic nephropathy.

Authors:  Xiaoxin X Wang; Tao Jiang; Moshe Levi
Journal:  Nat Rev Nephrol       Date:  2010-04-27       Impact factor: 28.314

Review 2.  Pharmacogenetics of posttransplant diabetes mellitus.

Authors:  P Lancia; T Adam de Beaumais; E Jacqz-Aigrain
Journal:  Pharmacogenomics J       Date:  2017-03-28       Impact factor: 3.550

3.  Hepatocyte nuclear factor 4α transactivates the mitochondrial alanine aminotransferase gene in the kidney of Sparus aurata.

Authors:  María C Salgado; Isidoro Metón; Ida G Anemaet; J Diego González; Felipe Fernández; Isabel V Baanante
Journal:  Mar Biotechnol (NY)       Date:  2011-05-24       Impact factor: 3.619

4.  Complete complement deficiency in a large cohort of familial systemic lupus erythematosus.

Authors:  R Aggarwal; A L Sestak; A D'Souza; A D'Sousa; S P Dillon; B Namjou; R H Scofield
Journal:  Lupus       Date:  2009-11-12       Impact factor: 2.911

5.  Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin.

Authors:  S Goswami; S W Yee; S Stocker; J D Mosley; M Kubo; R Castro; J A Mefford; C Wen; X Liang; J Witte; C Brett; S Maeda; M D Simpson; M M Hedderson; R L Davis; D M Roden; K M Giacomini; R M Savic
Journal:  Clin Pharmacol Ther       Date:  2014-05-22       Impact factor: 6.875

6.  Upregulation of Scavenger Receptor BI by Hepatic Nuclear Factor 4α through a Peroxisome Proliferator-Activated Receptor γ-Dependent Mechanism in Liver.

Authors:  Yi Zhang; Chen Shen; Ding Ai; Xuefen Xie; Yi Zhu
Journal:  PPAR Res       Date:  2011-11-14       Impact factor: 4.964

7.  A general integrative genomic feature transcription factor binding site prediction method applied to analysis of USF1 binding in cardiovascular disease.

Authors:  Tianyuan Wang; Terrence S Furey; Jessica J Connelly; Shihao Ji; Sarah Nelson; Steffen Heber; Simon G Gregory; Elizabeth R Hauser
Journal:  Hum Genomics       Date:  2009-04       Impact factor: 4.639

8.  Liver fat storage is controlled by HNF4α through induction of lipophagy and is reversed by a potent HNF4α agonist.

Authors:  Seung-Hee Lee; Vimal Veeriah; Fred Levine
Journal:  Cell Death Dis       Date:  2021-06-11       Impact factor: 8.469

Review 9.  Insights on pathogenesis of type 2 diabetes from MODY genetics.

Authors:  Michael N Weedon; Timothy M Frayling
Journal:  Curr Diab Rep       Date:  2007-04       Impact factor: 5.430

10.  HNF4alpha and HNF1alpha dysfunction as a molecular rational for cyclosporine induced posttransplantation diabetes mellitus.

Authors:  Jürgen Borlak; Monika Niehof
Journal:  PLoS One       Date:  2009-03-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.